We review how the use of Ki-67 in breast cancer has evolved over the past 40 years, with a summary of the present literature on Ki-67 in breast cancer, and a discussion on the future of Ki-67 as a prognostic and predictive marker for breast cancer in clinical practice. This evidence concerns the gene MKI67 and breast carcinoma.